Disease/Infection News

RSS

Molecular simulations provide insight into SARS-CoV-2 variant RBD interactions with ACE2 and mAbs

Researchers aimed to understand the relationship between the SARS-CoV-2 receptor-binding domain and both human receptors and therapeutic targets.

3 Feb 2022

Review confirms reduced severity of SARS-CoV-2 Omicron infection

Researchers review existing literature to quantify the transmissibility, immune evasion, reinfection, and severity of the SARS-CoV-2 Omicron variant.

3 Feb 2022

Understanding public responses to UK's COVID test, trace and isolate measures

Researchers investigate the public behaviors in response to the United Kingdom test, trace, and isolate (TTI) policy in July 2021.

3 Feb 2022

The spread of menstrual irregularity and COVID-19 vaccines concerns on the web

researchers discuss their findings from an analysis of data searches with a focus on menstrual irregularities and COVID-19 vaccine concerns.

3 Feb 2022

Evaluating effects of D614G and P681R/H mutations on SARS-CoV-2 VOCs

Researchers evaluate how the D614G and P681H mutations alter the attributes of SARS-CoV-2 VOCs.

3 Feb 2022

SARS-CoV-2 human challenge study offers novel insights into viral kinetics

Researchers discuss the results of a human challenge study to provide novel insights into the early dynamics of SARS-CoV-2 infection.

3 Feb 2022

Smartphone system sends COVID-19 exposure alerts to users in Missouri

Smartphones can help alert you if you've been exposed to someone with COVID-19. Washington University in St. Louis is expanding access to MO/Notify, a smartphone system that privately sends pop-up alerts to users in Missouri when they have spent time near someone who later tests positive for COVID-19.

3 Feb 2022

Global efforts to track COVID-19 variants grossly underreported a probable variant of concern in Nigeria

If the United States ignores COVID-19 in Nigeria, we forgo global genomic surveillance at our own peril, reports a new Northwestern Medicine study published in Nature Communications.

3 Feb 2022

Study shows positive outcomes in COVID-19 patients who underwent lung transplants

For many COVID-19 patients with irrecoverable lung damage, transplantation is the only option for survival. However, there is limited information about the long-term outcomes of these patients, including postoperative complications, hospital length of stay and survival.

3 Feb 2022

Older adults have greatest stroke risk in the first three days after COVID-19 diagnosis

The risk of stroke among older adults diagnosed with COVID-19 was highest within the first three days of diagnosis, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health to be held in person in New Orleans and virtually, Feb. 8-11, 2022.

3 Feb 2022

CDC report underscores the need to address social determinants that contribute to HIV disparities in the U.S.

Despite overall progress in reducing HIV transmission in the United States, HIV continues to affect some groups more than others due to longstanding and ingrained barriers.

3 Feb 2022

Nuvaxovid COVID-19 vaccine given regulatory approval By MHRA

Nuvaxovid, the COVID-19 vaccine developed by Novavax, has today been given regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA).

3 Feb 2022

Innate and adaptive immune responses to SARS-CoV-2 in convalescent children and adults

In a new study, researchers explored the systemic immune responses during the acute and convalescent phases of SARS-CoV-2 in children and adults with the same disease severity.

3 Feb 2022

Studying the efficacy of a SARS-CoV-2 vaccine booster dose

In a new study, a team of researchers assessed the efficacy of booster doses of Ad26.COV2.S (Jansen) SARS-CoV-2 vaccine.

3 Feb 2022

Relationship between SARS-CoV-2 neurotropism and Alzheimer's disease

In a new study, researchers evaluated the neurotropism of SARS-CoV-2 and its impact on COVID-19 patients with and without neurological disorders like Alzheimer's disease.

3 Feb 2022

Study reveals peripheral blood biomarkers able to predict COVID-19 clinical outcomes in ICU admission

A new study involved the development of an immunological biomarker screen that upon ICU admission can predict the length of ICU stay or death.

3 Feb 2022

The impact of the strict 112-day lockdown in Melbourne, Australia

Scientists recently evaluated the impact of 112-day strict lockdown implemented in Melbourne, Australia, to control the transmission of SARS-CoV-2.

3 Feb 2022

Exploring human milk oligosaccharides as a method of COVID-19 prevention

New research was conducted to ascertain whether antiviral and immunomodulatory activities of human milk oligosaccharides can be efficacious in the prevention and treatment against COVID-19.

3 Feb 2022

Sample management of Covid-19 Cryobox tube racks

Ziath reports on the widespread adoption of its DataPaq™ Cube rack reader in Covid-19 testing labs for tracking of sample tubes cryogenically stored in cryoboxes.

3 Feb 2022

Study finds no strong evidence to suggest vaccination improves symptoms of post-acute COVID-19 syndrome

In this study, researchers found no evidence of a strong effect of SARS-CoV-2 vaccination on the symptoms associated with PACS over time.

3 Feb 2022

Disease/Infection News

Molecular simulations provide insight into SARS-CoV-2 variant RBD interactions with ACE2 and mAbs

Review confirms reduced severity of SARS-CoV-2 Omicron infection

Understanding public responses to UK's COVID test, trace and isolate measures

The spread of menstrual irregularity and COVID-19 vaccines concerns on the web

Evaluating effects of D614G and P681R/H mutations on SARS-CoV-2 VOCs

SARS-CoV-2 human challenge study offers novel insights into viral kinetics

Smartphone system sends COVID-19 exposure alerts to users in Missouri

Global efforts to track COVID-19 variants grossly underreported a probable variant of concern in Nigeria

Study shows positive outcomes in COVID-19 patients who underwent lung transplants

Older adults have greatest stroke risk in the first three days after COVID-19 diagnosis

CDC report underscores the need to address social determinants that contribute to HIV disparities in the U.S.

Nuvaxovid COVID-19 vaccine given regulatory approval By MHRA

Innate and adaptive immune responses to SARS-CoV-2 in convalescent children and adults

Studying the efficacy of a SARS-CoV-2 vaccine booster dose

Relationship between SARS-CoV-2 neurotropism and Alzheimer's disease

Study reveals peripheral blood biomarkers able to predict COVID-19 clinical outcomes in ICU admission

The impact of the strict 112-day lockdown in Melbourne, Australia

Exploring human milk oligosaccharides as a method of COVID-19 prevention

Sample management of Covid-19 Cryobox tube racks

Study finds no strong evidence to suggest vaccination improves symptoms of post-acute COVID-19 syndrome

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News